LSDIF — Lucy Scientific Discovery Income Statement
0.000.00%
Last trade - 00:00- $0.00m
- -$0.14m
- $0.01m
- 21
- 83
- 33
- 43
Annual income statement for Lucy Scientific Discovery, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS/A | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0 | 0 | 0 | 0.007 |
| Cost of Revenue | ||||
| Gross Profit | — | — | — | 0.003 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 3.31 | 2.49 | 3.47 | 7.03 |
| Operating Profit | -3.31 | -2.49 | -3.47 | -7.02 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -3 | -4.73 | -5.86 | -8.99 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -3 | -4.73 | -5.86 | -8.99 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -3 | -4.73 | -5.86 | -8.99 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Dilution Adjustment | ||||
| Diluted Net Income | -3 | -4.73 | -5.86 | -8.99 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -1.57 | -3.02 | -3.6 | -6.09 |
| Dividends per Share |